Health care-associated pneumonia (HCAP): A critical appraisal to improve identification, management, and outcomes-proceedings of the HCAP summit

Kollef, Marin H., Morrow, Lee E., Baughman, Robert P., Craven, Donald E., McGowan, John E., Micek, Scott T., Niederman, Michael S., Ost, David, Paterson, David L. and Segreti, John (2008) Health care-associated pneumonia (HCAP): A critical appraisal to improve identification, management, and outcomes-proceedings of the HCAP summit. Clinical Infectious Diseases, 46 Suppl. 4: S296-S334. doi:10.1086/526355


Author Kollef, Marin H.
Morrow, Lee E.
Baughman, Robert P.
Craven, Donald E.
McGowan, John E.
Micek, Scott T.
Niederman, Michael S.
Ost, David
Paterson, David L.
Segreti, John
Title Health care-associated pneumonia (HCAP): A critical appraisal to improve identification, management, and outcomes-proceedings of the HCAP summit
Journal name Clinical Infectious Diseases   Check publisher's open access policy
ISSN 1058-4838
Publication date 2008-04-15
Sub-type Critical review of research, literature review, critical commentary
DOI 10.1086/526355
Volume 46
Issue Suppl. 4
Start page S296
End page S334
Total pages 39
Place of publication Chicago Ill., U.S.A.
Publisher University of Chicago Press.
Language eng
Subject 1103 Clinical Sciences
1117 Public Health and Health Services
Abstract Increasingly, patients are receiving treatment at facilities other than hospitals, including long-term-health care facilities, assisted-living environments, rehabilitation facilities, and dialysis centers. As with hospital environments, nonhospital settings present their own unique risks of pneumonia. Traditionally, pneumonia in these facilities has been categorized as community-acquired pneumonia (CAP). However, the new designation for pneumonias acquired in these settings is health care-associated pneumonia (HCAP), which covers pneumonias acquired in health care environments outside of the traditional hospital setting and excludes hospital-acquired pneumonia (HAP), ventilator-associated pneumonia (VAP), and CAP. Although HCAP is currently treated with the same protocols as CAP, recent evidence indicates that HCAP differs from CAP with respect to pathogens and prognosis and, in fact, more closely resembles HAP and VAP. The HCAP Summit convened national infectious disease opinion leaders for the purpose of analyzing current literature, clinical trial data, diagnostic considerations, therapeutic options, and treatment guidelines related to HCAP. After an in-depth analysis of these areas, the infectious disease investigators participating in the summit were surveyed with regard to 10 clinical practice statements. The results were then compared with results of the same survey as completed by 744 Infectious Diseases Society of America members. The similarities and differences between those survey results are the basis of this publication. © 2008 by the Infectious Diseases Society of America. All rights reserved.
Keyword Community-acquired Pneumonia
Ventilator-associated Pneumonia
Resistant Staphylococcus-aureus
Respiratory-tract Infections
Aminoglycoside Combination Therapy
Randomized Controlled-trial
Blood-stream Infections
Beta-lactam Monotherapy
Nursing-home Residents
Q-Index Code C1
Q-Index Status Provisional Code
Institutional Status Unknown

Document type: Journal Article
Sub-type: Critical review of research, literature review, critical commentary
Collection: UQ Centre for Clinical Research Publications
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 60 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 73 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Tue, 07 Sep 2010, 17:04:16 EST